SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " lying " 897 found 🔀 AI-powered Shuffle
Flying Pig partners with 1N5 on suicide prevention in Blue Jean Mile
One of the first and shortest events of the Flying Pig Weekend may be its most impactful. Here's how 1N5 is using the Blue Jean Mile to promote mental health.
House Passes Stalled Homeland Security Funding Bill, Ending Shutdown
Republicans were forced to use a special maneuver to steer around opposition in their own party and speed the measure to the floor, relying on Democrats to push it through.
Resiliency remains key to Golden Knights' success
Rallying from deficits is a strength that has been evident virtually all season.
Unilever Sales Rise Amid Portfolio Overhaul
Underlying sales rose 3.8%, as the consumer-goods company carries out its largest portfolio shuffle yet.
Viewpoint: A career in science is possible, and worth it
Starting a career in science is exciting, but also demanding, with researchers often faced with intense competition, long working hours and high levels of stress. A pioneer in the field of mass spectrometry, Carol Robinson has been there. She speaks with Science|Business on the importance of creating a supportive environment, particularly for women.Robinson did not wake up one day thinking that she would become a scientist. It was only late in school that she developed an interest in chemistry. “The more you work at something, the more you think, actually, this is fascinating. So, I went much further and deeper than I ever needed to pass the exam. And then I loved it,” she says. “I thought, I’m going to give it my all. I’m going to enjoy it while I’m here. But I didn’t think this would be my career for 50 odd years.”She left school at 16 to become a lab technician with the drug company Pfizer, which is where she first worked with mass spectrometry. Fascinated, she was encouraged to take a part-time degree and then a PhD. She went on to do pioneering work in native mass spectrometry, a technique that is used to study protein structures in their natural state, paving the way for breakthroughs in drug discovery. She also broke new ground by becoming the first female professor of chemistry at the University of Cambridge, and then the first female professor of chemistry at the University of Oxford, her current home.She now wants to show young researchers that a career in science is worth it. “Sometimes, I believe the culture isn’t very encouraging, and that’s something I have worked on,” Robinson says.In 2021, she launched the Kavli Institute for Nanoscience Discovery at Oxford, whose acronym gives a sense of what she hopes it will achieve. “Maybe it is corny,” she says. “It’s just a reminder that I would like it if we could all be kind to each other and supportive, especially for early-career researchers of either gender, because there’s quite a big attrition rate in science, and maybe it just doesn’t feel like a very friendly place to work.”And yet, a career in science comes with a lot of flexibility. “There are few careers where you have that amount of freedom, to go to conferences, to the library. Just because you didn’t see me didn’t mean I wasn’t working,” she says. “And I’m excited to come in every day. So, I don’t want people to think it’s a terrible place.”Gender equality is also important when it comes to the quality of science as a career. “The more women we have, the better it becomes,” Robinson adds.Imposter syndromeAccording to EU data, women outnumber men in university education but account for just about a third of graduates in science, technology, engineering and mathematics (Stem). And while the number of women working as scientists and engineers in the 27-member bloc is on the rise, their representation remains below that of men, at 41%. This discrepancy is even more pronounced in top-tier functions across these fields, where women fill just 20% of positions.Having supervised many young scientists, Robinson sees that women continue to have a greater propensity than men to doubt their abilities, a feeling she once shared. “When I was doing my PhD at the University at Cambridge, I really felt like an imposter,” she says. “I don’t think I ever felt I deserved to be there or owned it and was proud. I just thought I was lucky.” Later on, she adds, “I was always that person who said, I can’t apply yet because my CV is not strong enough.”She has now made it her job to encourage women to break with this imposter syndrome. For example, rather than calling for volunteers to give a lecture in the groups that she mentors or teaches, which nearly always results in men stepping forward, she goes straight to the women, “because I know they won’t push themselves forward.”But the gender gap in science is not just down to imposter syndrome. The “obvious” reason, Robinson says, and the reason that is on everybody’s mind when discussing workplace gender equality, is the balance between work and raising a family. Her own path was to choose between the two, taking an eight-year break after completing a postdoctoral training fellowship to bring up three children. And she continues to advise women not to work part-time while they raise a family. “You’ll just get half the pay and continue to work full-time because you are not able to fit everything in,” she says. “You should be able to have a family and come back to have the career that you want.”The solution is for men to also take career breaks. “That kind of evens it up, so that it’s not such a big thing for women,” Robinson says. “I always encourage men in my groups to do that. I think it’s important to take your share of the duties.”Support produces resultsAccording to the Women in Stem Network, a UK advocacy group, countries with strong childcare systems and equal pay policies retain more women in technical careers. In Europe, these are primarily found in the Nordic region and parts of central Europe.At the EU level, the European Commission asks all Horizon Europe applicant organisations to have a gender action plan in place. Since this criterion was introduced in 2021, the share of women leading consortia has increased to 31%, against 23% in Horizon 2020. Their overall participation, however, has risen just 1%, to 38%. After trying to weaken the requirement for gender action plans in 2025, the Commission now intends to adopt a plan for supporting women in research and innovation.Related articlesCommission scraps plan to water down gender requirements in HorizonHow gender balance can swing who wins Horizon Europe fundingRobinson herself has benefited from three Advanced Grants from the European Research Council. “I was extremely honoured and privileged to get those, because they really allowed me to fuel my passion,” she says. “Without that, it would have been a much harder slog.”Beyond applying gender rules, she says that more work is needed on translational enterprise, where women are, once again, largely underrepresented. The European Patent Office found that only 13.8% of applications were filed by women in 2022. “We have so many more women doing amazing science; why do they feel it’s not a thing to have a company?” she asks.She founded her own spin-out company, OMass Technologies, in 2016, and remains chair of its scientific advisory board now that it trades as OMass Therapeutics. As for research, Robinson is now studying how changes in the brain may be linked to depression, using port-mortem tissue. “We’re hoping to publish soon,” she says. “We had to consult with a lot of people who knew a lot more about the brain than we did. So, we’ve learnt a lot, and that’s always a lot of fun to learn a new thing. That’s what keeps you going.”
Top 10 things to do this weekend. Piggies, tacos and a big horse race
Don't miss all the fun festivities this weekend, with Flying Pig Marathon Weekend and Cincy-Cinco Latino Cultural Festival upon us.
Australia becomes the 30th country to eliminate trachoma as a public health problem
The World Health Organization (WHO) has validated Australia for eliminating trachoma as a public health problem, marking a significant milestone in the health of indigenous peoples and in global efforts to combat neglected tropical diseases (NTDs). Trachoma, the world’s leading infectious cause of blindness, no longer represents a public health problem in the country.Australia is among a growing number of countries that have successfully eliminated trachoma, contributing to global progress towards the targets set out in the WHO road map for NTDs 2021–2030.Trachoma is caused by the bacterium Chlamydia trachomatis and spreads through close contact with infected individuals, contaminated surfaces, and flies that carry eye and nose discharge. Repeated infections can lead to scarring of the eyelids, turning eyelashes inward, and ultimately causing blindness if untreated.“WHO congratulates Australia on this important achievement,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This success reflects sustained commitment, strong partnerships, and a focus on reaching populations most affected by health inequities. It brings us closer to a world free from the suffering caused by trachoma.”Australia’s journey to eliminationAustralia’s achievement reflects decades of targeted public health action, particularly in remote Aboriginal and Torres Strait Islander communities, where trachoma persisted despite its earlier disappearance from the rest of the country.National efforts intensified with the establishment of the National Trachoma Management Programme in 2006, which implemented the WHO-recommended SAFE strategy: surgery for trichiasis, antibiotics to treat infection, promotion of facial cleanliness, and environmental improvement. Regular screening of all communities classified as at-risk of trachoma by teams of qualified health workers formed an important part of the Programme. Interventions were delivered through coordinated partnerships between federal and state governments, Aboriginal community-controlled health services, and local communities.Over time, sustained screening, treatment, and prevention activities, including improvements in housing, water, sanitation and hygiene, led to a steady decline in trachoma prevalence. Australia’s approach included adaptations to reflect its context, such as targeted treatment based on community-level data rather than mass drug administration, and strong integration with environmental health programmes.“Elimination of trachoma is a win for the eye health of communities across Australia, particularly those whose lives have been impacted by a disease that is entirely preventable,” said Mark Butler, Minister for Health and Ageing, Australia. “This major milestone is thanks to Aboriginal and Torres Strait Islander leadership, community commitment and sustained investment over many decades.“The lessons from this work will inform how we approach other preventable health conditions in remote and regional Australia. Aboriginal Community Controlled Health Organisations and local health workers have been central to this success, delivering culturally safe care and community-led solutions.”“This recognition from the World Health Organization reflects decades of work led by Aboriginal Community Controlled Health Organisations, alongside local health workers in remote First Nations communities,” said Malarndirri McCarthy, Minister for Indigenous Australians. “Their work has been critical to eliminating trachoma as a public health problem in Australia.”Advancing global efforts against neglected tropical diseases (NTDs)Trachoma is one of 21 diseases and disease groups that are regarded by WHO as NTDs. Together, NTDs affect more than 1 billion people worldwide, primarily in underserved populations with limited access to essential services such as clean water, sanitation, and health care.Australia’s elimination of trachoma as a public health problem highlights the importance of sustained political commitment and cross-sectoral collaboration in addressing the underlying determinants of health. It also underscores the feasibility of eliminating trachoma even in geographically challenging settings.In addition to trachoma, Australia has several endemic NTDs, including Buruli ulcer, leprosy and scabies. Validation of elimination of trachoma as a public health problem marks the first time that WHO has confirmed the elimination of an NTD in Australia, which becomes the 63rd country globally and 16th in the Western Pacific Region to have eliminated at least one NTD.“Tackling neglected tropical diseases in the Western Pacific Region has long been a challenge for countries across the socioeconomic spectrum, given the complexities in reaching the most vulnerable communities, including in remote areas,” said Dr Saia Ma’u Piukala, WHO Regional Director for the Western Pacific. “As a doctor from Tonga, I’ve experienced these challenges for myself. But I also know that with strategic commitment underpinned by optimal resources and partnerships in health, success is possible as other countries in our region have also demonstrated. I commend Australia on eliminating trachoma as a public health problem and urge all involved to remain vigilant to ensure this status is maintained.”WHO continues to support countries working to eliminate trachoma and other NTDs, ensuring that progress reaches those most in need and that gains are sustained through strong surveillance, appropriately integrated into national health systems, and mainstreamed within the wider health sector and beyond.Editor’s notesNeglected tropical diseases and trachoma elimination effortsNeglected tropical diseases are associated with devastating health, social and economic consequences. Their burden is mainly felt among impoverished communities in tropical areas.Public health targets for the control, elimination and eradication of these conditions were set in the road map for neglected tropical diseases 2021–2030 (https://www.who.int/publications/i/item/9789240010352).In 1996, WHO launched the WHO Alliance for the Global Elimination of Trachoma by 2020 (GET2020), creating a network of governments, non-governmental organizations and academic institutions dedicated to the fight against trachoma. WHO continues to support endemic countries to accelerate progress towards the global target of eliminating trachoma as a public health problem worldwide; 2030 is the new target date.Elimination of trachoma as a public health problem is defined as: (i) a prevalence of trachomatous trichiasis (TT) “unknown to the health system” of < 0.2% in ≥15-year-olds; and (ii) a prevalence of trachomatous inflammation—follicular (TF) in children aged 1–9 years of < 5%, in each formerly endemic district, plus (iii) the existence of a system to identify and manage incident cases of TT.Other countries validated by WHO as having eliminated trachoma as a public health problem are: Algeria, Benin, Burundi, Cambodia, China, Egypt, Fiji, Gambia, Ghana, India, Iraq, Islamic Republic of Iran, Lao People’s Democratic Republic, Libya, Malawi, Mali, Mauritania, Mexico, Morocco, Myanmar, Nepal, Oman, Pakistan, Papua New Guinea, Saudi Arabia, Senegal, Togo, Vanuatu and Viet Nam.
Global health PhD grad gains perspective through real-world health care experience
Instead of relying solely on the classroom to learn about global health systems, Adrienne Madhavpeddi took a different route during her time in graduate school, working with multiple organizations to gain real-world experience in the health care field.Originally from Red Deer, Alberta, Canada, Madhavpeddi will be graduating from Arizona State University’s School of Human Evolution and Social Change with her PhD in global health this May.
Your job can actually kill you: More than 840,000 people die annually from health conditions linked to work stress, ILO report says
A new ILO report says long hours, job insecurity, bullying, and other psychosocial risks at work are tied to a total 1.37% loss of the global GDP.
How Trump’s FCC Has Already Changed the Media (Possibly Forever)
Critics — including commissioners in the agency — have accused FCC chair Brendan Carr of bullying media companies into bowing to conservative policy goals.
Healthy life expectancy gap between rich and poor has widened
Poor housing, obesity and the effects of deprivation have been suggested as underlying causes of the fall.
Nessus Agent Vulnerability on Windows Enables Arbitrary Code Execution with SYSTEM Privileges
A newly disclosed security vulnerability in Tenable's Nessus Agent for Windows could allow attackers to execute malicious code with the highest level of system privileges, raising serious concerns for enterprise security teams relying on the widely-deployed vulnerability assessment platform.
How ‘Storage Wars’ Paid Tribute to Darrell Sheets on Air, 3 Days After His Death
Meanwhile, authorities are investigating the cyberbullying accusations mentioned by ‘Storage Wars’ costar René Nezhoda.
How ‘Storage Wars’ Paid Tribute to Darrell Sheets on Air, 3 Days After His Death
Meanwhile, authorities are investigating the cyberbullying accusations mentioned by ‘Storage Wars’ costar René Nezhoda.
Things to do in Cincinnati this week, April 27-May 3
If you're looking for the best events happening in Cincinnati, you're at the right place. Find your next concert, game, festival or family event.
Cut in half: Nike ACG Ultrafly Trail Review (2026)
Nike ACG Ultrafly Trail review: Nike clearly listened to feedback from the first Ultrafly, and the ACG reboot delivers a much better product. We found in the lab that the new dual-plate setup, upgraded ZoomX foam, and lower weight create a true trail super shoe that surprised us right away. It's perfect for flying over gravel roads or easy, flat trails. The premium price is hard to ignore, and the high drop may divide opinions, but in our view, this is an amazing weapon for crushing all your personal bests.
New “optical tornado” technology could transform quantum communication
Scientists have created tiny “optical tornadoes” — swirling beams of light that twist like miniature whirlwinds — using a surprisingly simple setup based on liquid crystals. Instead of relying on complex nanotechnology, the team used self-organizing structures called torons to trap and manipulate light, causing it to spiral and rotate in intricate ways. Even more impressively, they achieved this effect in light’s most stable, lowest-energy state, making it far easier to generate laser-like beams with these unusual properties.
Is Tencent Music Entertainment Group (NYSE:TME) Pricing Reflect Recent Slide And DCF Upside Potential
If you are wondering whether Tencent Music Entertainment Group's current share price reflects its underlying value, or if the market is mispricing it, this breakdown will help you frame that question with numbers rather than guesswork. The stock last closed at US$9.25, with returns of an 8.9% decline over 7 days, a 6.2% decline over 30 days, a 48.2% decline year to date, a 28.6% decline over 1 year, a 32.8% gain over 3 years, and a 45.6% decline over 5 years, which gives you a wide range of...
The best way to sleep on a plane, according to science
An eye mask, earplugs, and a same-day workout can all increase your odds.
Modified Boeing 777 Will Become NASA’s Largest Flying Science Lab
Heavily modified 777 is scheduled to fly its first NASA science mission in January.
UM Health-Sparrow named among the top maternity hospitals in the country
UM Health-Sparrow has been named one of the best hospitals in the United States for maternity care, earning a four-ribbon designation on Newsweek’s “America’s Best Maternity Hospitals 2026.”
Bullying, Politics Harm Mental Health Of Gender-Diverse Teens
By Dennis Thompson HealthDay ReporterWEDNESDAY, April 22, 2026 (HealthDay News) — Gender-diverse teenagers who are bullied are more likely to suffer escalating psychological distress than other teens, particularly if they live in a state with repressive gender identity laws, a new study says. These ...
Sen Warren: either Trump or his Fed nominee is lying about demands to lower interest rates
Kayleigh McEnany: Politicians have been ‘lying to you’
‘Saturday in America’ host Kayleigh McEnany discusses the Democratic Party’s stance on the Iran conflict and President Donald Trump’s response on ‘Jesse Watters Primetime.’
Google Wallet just got a big upgrade ahead of the busy travel season
It makes flying less of a hassle
Local student turns science into savings
At a time when many students are just beginning to explore the basics of science, Thomas Jones, current 8th grade student at Lincoln County Middle School, is already applying advanced […]
Napping may be warning sign of health issues in older adults, study finds
For older adults, naps may be a warning sign of underlying conditions or declining health, according to a new study.
When the CEO Becomes the Brand
Research suggests that Elon Musk’s political stance appears to have reshaped how different groups perceive Tesla. Overall sales trends hint at trouble. The company’s growth stalled in 2024, and deliveries fell 8.5% in 2025. But those headline numbers hide what is happening beneath the surface. When the data is broken down by political orientation and by changes in views of Musk, a more complicated pattern emerges. Among right-leaning respondents and those whose opinion of Musk has improved, Tesla’s brand appeal is significantly higher and willingness to pay exceeds that for many competing brands, including Ford, Chevrolet, and Rivian. Among left-leaning consumers and those whose view of Musk has worsened, the opposite is true: Preference and willingness to pay for Tesla drop sharply. The outcome is not a uniform decline but a polarization of demand. Some consumers appear to feel alienated, while others feel more aligned with the brand. This raises an important strategic question of whether companies can influence purchasing decisions across these divided segments by strengthening the underlying value proposition.
Legislation that could lead to faster election results advances
The Pa. House State Government Committee has advanced a bill that would allow election officials to begin opening and tallying mail-in ballots before Election Day, speeding election result reporting.
Romania Coalition Nears Collapse as Top Party Spurns Premier
Romania’s government has been thrown into turmoil after the top ruling party withdrew its support for Prime Minister Ilie Bolojan, whose own bloc is now rallying to salvage his control of the four-way coalition.
New York businesses can seek Trump tariff refunds; Hochul demands White House repay consumers $1,700 per household
New York businesses can now begin applying for refunds tied to President Donald Trump's tariffs that the U.S. Supreme Court found were imposed illegally,
Six ways your smartwatch is lying to you, according to science
Wearable fitness technologies like smartwatches are worn by millions of people daily. But they're not as accurate as you might think.
Daytime napping patterns may reveal hidden health decline in older adults
New research reveals that as people age, naps may be an easily trackable warning sign of underlying conditions or declining health. A new study by investigators from Mass General Brigham and Rush University ...
Therapist unpacks social media’s impact on teen mental health, friendships
Child and adolescent family therapist Darby Fox discusses new research on how teens perceive social media. Many credit Snapchat with helping friendships, but most report online harassment and bullying.
Cubs hand Mets their 11th straight loss by rallying for a 2-1 win in 10 innings
It’s the longest losing streak for the Mets since 2004.
What to know about tariff refund site that's set to go live Monday
This is the 1st phase in the administration complying with court orders that could see billions of dollars in paid tariffs refunded.
6 ways your smartwatch is lying to you, according to science
Smartwatches aren’t always as accurate as you might think. In some cases, you’d be better off listening to your body.
Is It Too Late To Consider Guardant Health (GH) After Its 100% One Year Surge?
If you are wondering whether Guardant Health at around US$90.36 is still fairly priced or starting to look stretched, the key question is what that tag says about the underlying business. The stock has seen sharp swings, with a 15.0% move over the last 7 days, 6.1% over 30 days, a 100.9% return over 1 year and a 268.7% return over 3 years, while the 5 year return sits at a 42.9% decline and the year to date return at an 11.2% decline. Recent headlines around Guardant Health have focused on...
Stanford grad couldn't find job, so created a six-figure business
I thought I was overqualified for most of the jobs I was applying for as a Stanford grad. I started my own PR company, and it's been successful.
Powhatan State Park to host Birding for Science event
Powhatan State Park is hosting a Birding for Science event this weekend to help identify and learn more about who’s flying around this time of year.
The New Inflight Entertainment System That Emirates Passengers Are Raving About
The arrival of the first Airbus A350-900 into the Emirates fleet has brought a revolution to the back of seat screens.
This Stock Has No Business Being This Good and It Just Keeps Going
This highly cyclical company has increased its dividend annually for 53 years, which is an incredible feat.
Scientists solve 100-year-old mystery behind rubber that powers modern life
Every time you drive, board a plane or water your lawn, you're relying on a material that has quietly powered modern life for nearly a century—reinforced rubber. It's in car and aircraft tires, industrial ...
The People’s Airline: How Southwest turned love into a business model
Southwest Airlines proved that flying didn't have to be a luxury. By treating employees and customers like family, the company transformed air travel.
Beyond the Dialysis Machine: Shaping the Future of Kidney and Cardiovascular Health
At Yale School of Medicine, Christopher El Mouhayyar, MD, works at the forefront of managing dialysis treatment in patients while addressing underlying disease.
In letter to Xi, Trump asks China not to send weapons to Iran
Trump warns China against supplying weapons to Iran, says Xi Jinping responded with a letter claiming he is not providing arms to the country.
Report: iPad Air to Gain OLED Display Next Year
Apple will bring OLED displays to its iPad Air models next year, according to a new report from Korea's ET News. Citing industry sources, the outlet says Samsung Display will begin mass production of OLED panels around the end of 2026 or January next year, with a view to supplying panels for Apple's next iPad Air, expected to be released in early 2027. Apple last updated the iPad Air in March 2026 with an M4 chip.
How American, Delta, and United's newest business class suites compare
Doors in business class are now the baseline of premium flying as deep-pocket travelers keep paying up for more privacy and comfort.
'Deeply grateful': Darren McAuley passes $530K in donations, flying past Dem field in CD 15
He wrapped the quarter with $265,000 in cash on hand.
A new way to detect life beyond Earth without knowing what life looks like
Researchers from the Earth-Life Science Institute (ELSI) and National Institute for Basic Biology have developed a new method to detect extraterrestrial life without relying on traditional biosignatures. By modelling how life might spread between planets, they demonstrate that life could be detected through statistical patterns across planetary populations rather than on individual planets. This "agnostic biosignature" approach could assist in guiding future searches for life beyond Earth.
Balloons Over Bend Brings Family Fun, Night Glows & High-Flying Entertainment to Central Oregon
The REMAX Key Properties Balloons Over Bend is set to return July 24–26, 2026, bringing a weekend of hot air balloon launches, live entertainment, and community celebration to Central Oregon. This signature summer event will feature free sunrise balloon launches each morning, vibrant Night Glow celebrations, and activities for all ages. “Bend is more than a […]
Italy's surprise rise in exports to US masks deep fragility to tariffs
Italy was the only major EU country whose exports to the United States grew last year despite Donald Trump's tariffs. The result was hailed by Rome's government, but a closer look at the data shows one-off factors at play and little underlying resilience.
Asking Eric: ‘Very online’ girlfriend shares too much with strangers
Letter writer is weirded out by strangers replying to girlfriend’s posts about them.
Businesses look back at a week fueled by Merrie Monarch rush
With thousands flying into Hawaii Island, it’s a crucial sales week for local businesses, but many are navigating steep prices and high operating costs.
🗞️Today's headlines: No giving up, and a flying Lamine
The week begins revving up ahead of the Champions League quarter-final second legs.It is the week of truth for Madrid, Barça and Atleti in the Champions League, and the sports press wakes up with ral...
The largest orbital compute cluster is open for business
Kepler Communications is flying 40 GPUs in Earth orbit. And its latest customer is Sophia Space.
The largest orbital compute cluster is open for business
Kepler Communications is flying 40 GPUs in Earth orbit. And its latest customer is Sophia Space.
Marshals Season 1, Episode 7 Recap: “Family Business”
Kayce and the Marshals team make time for little love—between bouts of bullets flying, of course.
How Golden Entertainment (GDEN) Narratives Are Shifting As Analysts Recut Targets And Takeover Nears
Golden Entertainment’s fair value estimate has been nudged from US$30.50 to US$30.00 per share, a small adjustment that still keeps the story focused around a US$30 mark. Some analysts view this US$0.50 trim as an incremental shift that reflects updated valuation inputs rather than a major change in the underlying outlook, while more cautious voices see it as a signal of reduced conviction at recent prices. As you read on, you will see how this updated target fits into the evolving analyst...
Doctors expose ‘buffalo hump’ as potential sign of hidden health conditions
A "buffalo hump" — a fatty bulge at the base of the neck — can sometimes signal underlying medical conditions, experts say. Causes range from poor posture to hormonal disorders.
The Complex Transformations Underlying MC Escher’s Works
Self-similar images are rather common, which are images in which the same image is repeated on a smaller scale somewhere within the image that one is looking at, something which is also referred to…
In praise of popular science
As a kid, I was enthusiastically and unreservedly in favor of a manned space program. Our destiny lay in the stars, I figured. Get people out there. We need Star Trek here and now. As I got older, I became rather disenchanted with the idea. Humans are expensive, fragile, and inefficient as space cargo. We could flood the solar system with 100 robotic probes for the price of any single manned mission and get back just as useful data. Besides, it turns out space travel is dangerous. Tusk is a reader-supported publication. To support this work, please become a paid subscriber. Subscribe When it came to the recent Artemis II mission, my cynical side didn’t really see the point. Flying around the Moon and back is literally something we did before I was born, and I once owned a Members Only jacket. Apollo 8 circled the Moon ten times and returned to Earth safely the same month that “Chitty Chitty Bang Bang” was released. What was the point of repeating a feat that far braver people once did with tin foil and slide rules? Yet I’ve surprised myself with how moving I’ve found the Artemis II mission to be. The photos have been stunning. The crew has been professional and engaging. There have been modest but important milestones — the farthest humans have travelled from Earth; the first woman, person of color, and non-American to leave low-Earth orbit; innovations in communication, and more. One thing that really stood out is that this is really NASA at its finest. Not that this is the most important mission they ever pulled off, but they did this in a competent way that celebrated the achievements and kept the crew and the science at the forefront of the project. This wasn’t some billionaire throwing celebrities or cars into orbit as a vanity project — this was a collective effort to send experts in to do a job and come home safely. We don’t see that sort of thing much these days. I’m guessing few people would describe many government agencies as inspiring, but this one counts for me. We’re living through a profoundly anti-science era, in which pathbreaking, lifesaving discoveries like mRNA vaccines are routinely downplayed or even vilified. As I’ve noted previously, this era is something like that of the Red Scare in the 1940s and 50s, in which “egghead” professors were portrayed as out of touch or even hostile to regular Americans. One of the things that helped break that spell was Sputnik — the Soviet communications satellite that demonstrated that the United States was falling behind in crucial scientific research and applications. Its launch triggered a new appreciation for American science and goaded the federal government into supporting research universities and labs. I’m not saying that Artemis is the equivalent of Sputnik, but it potentially reminds people that there’s some value to scientific endeavors and the human faces attached to them. Despite my love for the show “For All Mankind,” I’m far from convinced that there’s any real value to putting colonies on the Moon or Mars that would justify the capital investment and the massive health risks to the astronauts. But sending scientific good will ambassadors on a trip into space once in a while? Bring it. Share
Iran Unable to Find Mines in Strait of Hormuz, U.S. Says
The lost mines have prevented Iran from quickly complying with President Trump’s demand to allow more ships to pass through the waterway.
Arizona House passes bill restricting drones near large entertainment events
The bill would make it illegal to fly a drone within a mile of a ticketed entertainment event at venues with at least 1,000 people capacity.
Trump is bullying NATO again. But Americans like the alliance
For the second time in the still-quite-young 2026 calendar year, President Donald Trump is threatening to blow up the North Atlantic Treaty Organization, which Americans decidedly like, over a foreign policy adventure they decidedly do not.
Microsoft starts removing Copilot buttons from Windows 11 apps
The underlying AI features are here to stay, though
St. Denis neighbors push back against business applying for liquor license
Less liquor stores and more community resources: that’s what residents of the St. Denis neighborhood are hoping for as they push back against a business applying for a liquor license.
The Slow Dismantling of American Science (and What We Can Do about It)
A rallying call to scientists: you have more power than you think to resist the politicization of your work.
BYU-Idaho Students Accepted to Health Professional Schools at Above-Average Rates
BYU-Idaho students applying to professional health programs during the 2024–2025 cycle achieved high acceptance rates to various medical schools.
Delta, Southwest hike checked bag fees as airlines face surging fuel costs
Flying is about to get pricier for some travelers as Delta and Southwest hike checked baggage fees to $45 for the first bag amid surging jet fuel costs.
UIndy Researchers Recognized by Indiana Academy of Science
Rochelle Maxson ’26 and Dr. Marc Milne, professor of biology, were awarded for their work at the annual meeting of the Indiana Academy of Science (IAS). The IAS seeks to bring together Indiana scientists, researchers, and educators across all disciplines to share discoveries and advance science. The Academy’s 2026 meeting had a record number of
With Orion still flying, NASA is nearing key decisions about Artemis III
One of the questions is what the initial orbit will be for Artemis III."
Applying for jobs wasn't working, so I started own business
After about nine months of job searching, Chris Fong started posting videos about his experience. He's stopped applying and hopes to build a business.
Democratic ally lays out health affordability plan
Democrats are increasingly talking about lowering underlying health care costs.
Vance makes time to visit Hungary to support Orbán amid Iran negotiations
The war with Iran is raging, gas prices continue to rise and spending battles persist on Capitol Hill. So why is the number two man in the White House flying to Budapest?
Medicare delays prior authorization pilot program for key interventional radiology service
CMS officially announced the move on April 6, with it applying to the Wasteful and Inappropriate Service Reduction (WISeR) Model.
Column: Trump's cries of cheating on mail-in ballots defy logic
President Trump and MAGA Republicans are hallucinating or outright lying about widespread election fraud.
What the Nike CEO’s remarks reveal about rallying employees through turnaround fatigue
His employees are exhausted. So is he.
AI breakthrough cuts energy use by 100x while boosting accuracy
AI is consuming staggering amounts of energy—already over 10% of U.S. electricity—and the demand is only accelerating. Now, researchers have unveiled a radically more efficient approach that could slash AI energy use by up to 100× while actually improving accuracy. By combining neural networks with human-like symbolic reasoning, their system helps robots think more logically instead of relying on brute-force trial and error.
Flying in Korean Air's upgraded business class suite; mostly worth it
I spent hours in Korean Air's upgraded business class, Prestige Suites 2.0. The seat, food, and amenities on my flight were great despite one con.
NASA shoehorns in human science on Artemis II moon mission
“The most complex machine we’re flying is the human, and we have to understand the human as a system in order to be successful.”
What it's like flying Southwest after all the changes; A-List helped
I hit the spending threshhold on my Chase Reserve card in 2025 to secure free A-List status on Southwest. Now, I wouldn't fly the airline without it.
Gemma 4 and what makes an open model succeed
Having written a lot of model release blog posts, there’s something much harder about reviewing open models when they drop relative to closed models, especially in 2026. In recent years, there were so few open models, so when Llama 3 was released most people were still doing research on Llama 2 and super happy to get an update. When Qwen 3 was released, the Llama 4 fiasco had just gone down, and a whole research community was emerging to study RL on Qwen 2.5 — it was a no brainer to upgrade. Today, when an open model releases, it’s competing with Qwen 3.5, Kimi K2.5, GLM 5, MiniMax M2.5, GPT-OSS, Arcee Large, Nemotron 3, Olmo 3, and others. The space is populated, but still feels full of hidden opportunity. The potential of open models feels like a dark matter, a potential we know is huge, but few clear recipes and examples for how to unlock it are out there. Agentic AI, OpenClaw, and everything brewing in that space is going to spur mass experimentation in open models to complement the likes of Claude and Codex, not replace them. Especially with open models, the benchmarks at release are an extremely incomplete story. In some ways this is exciting, as new open models have a much higher variance and ability to surprise, but it also points at some structural reasons that make building businesses and great AI experiences around open models harder than the closed alternatives. When a new Claude Opus or GPT drops, spending a few hours with them in my agentic workflows is genuinely a good vibe test. For open models, putting them through this test is a category error. Something else to be said about open models in the era of agents is that they get out of the debate of integration, harnesses, and tools and let us see close to the ground on what exactly is the ability of just a model. Of course, we can’t test some things like search abilities without some tool, but being able to measure exactly the pace of progress of the model alone is a welcome simplification to a systematically opaque AI space. Share The list of factors I’d use to assess a new open-weight model I’m considering investing in includes: Model performance (and size) — how this model performs on benchmarks I care about and how it compares to other models of a similar size. Country of origin — some businesses care deeply about provenance, and if a model was built in China or not. Model license — if a model needs legal approval for use, uptake will be slower at mid-sized and large companies. Tooling at release — many models release with half-broken, or at least substantially slower, implementations in popular software like vLLM, Transformers, SGLANG, etc due to pushing the envelope of architectures or tools. Model fine-tunability — how easy or hard it is to modify the given model to your use-case when you actually try and use it. The core problem is that some of these are immediately available at release, e.g. general performance, license, origin, etc. but others such as tooling take day(s) to week(s) to stabilize, and others are open research questions — with no group systematically monitoring fine-tunability. In the early era of open models, the days of Llama 2 or 3 and Qwen pre v3.5, the architectures were fairly simple and the models tended to work out of the box. Some of this was due to the extremely hard work of the Llama, Qwen, Mistral, etc. developer teams. Some is due to the new models being genuinely harder to work with. When it comes to something like Qwen 3.5 or Nemotron 3, with hybrid models (either gated delta net or mamba layers), the tooling is very rough at release. Things you would expect to “just work” often don’t. I’ve been following this area closely since we released Olmo Hybrid with a similar architecture, and Qwen 3.5 is just starting to work well in the various open-source tools that need to all play nice together for RL research. That’s 1.5 months after the release date! This is just to start really investing more into understanding the behavior of the models. Of course, others started working on these models sooner by investing more engineering resources or relying on partially closed software. The fully open and distributed ecosystem takes a long time to get going on some new models. All of this is lead-in for the most important question for open models — how easy is it to adapt to specific use-cases? This is a different problem for different model sizes. Large MoE open-weight models may be used by entities like Cursor who need complex capabilities in their domain, e.g. Composer 2 trained on Kimi K2.5. Other applications can be built on much smaller models, such as Chroma’s Context-1 model for agentic search, built on GPT-OSS 20B. The question of “which models are fine-tunable” is largely background knowledge known by engineers across the industry. There should be a thriving research area here to support the open ecosystem model. The first step is to understand characteristics of different base and post-trained models to understand what they look like. The second step is to tune pretraining recipes for open models so they’re more flexible. Interconnects AI is a reader-supported publication. Consider becoming a subscriber. Subscribe For The ATOM Project and other Interconnects endeavors, we’ve put in substantial effort to measuring adoption trends in the open ecosystem. Everything takes a long time to unfold after a model is first publicly available — and adaptability is why. What we know for sure now, when Qwen has been going from strength to strength with its releases, is that technical staff across the industry has gotten comfortable working with Qwen models. Countless research methods and datasets were made to work with Qwen. It’ll take patience for any other model family to get to this point — a patience I’m not sure many open model builders have. This takes us to Gemma 4, Google’s latest open models. Gemma 3 was released more than a year ago, in March of 2025, and is a bit underrated. Gemma 4 comes in 4 sizes for now, with a bigger, MoE model of over 100B total parameters rumored but not released yet. The models we have today come in sizes of ~5B dense, 8B dense, 26B total 4B active MoE, and 31B dense. I’m most excited that they’re finally adopting a standard Apache 2.0 open source license. This’ll massively boost adoption. The standard of better licenses for strong open-weight LLMs was set by mostly Chinese open model labs in the last 1-2 years, and now U.S. companies are following suit. I will personally be so happy if the horrible Llama licenses and Gemma terms of service were an ~18-month transient dynamic of the industry being nervous about releasing strong open models. The Gemma 4 scores look very solid, the small models have incredible benchmark scores (especially in general domains like LMArena) and the 31B model rivals the recent Qwen 3.5 27B, which is the leading member of that class. The ~30B size range is an important one, as it’s accessible both to researchers and to enterprises looking to deploy the model in real use-cases. Where the 7B model scale is the default for tinkering and research, a 30B model is the default for seeing if an open model can unlock substantial value in your specific workflow — a good mix of intelligence, low price, tractability for downstream training, etc. This takes us back to the above adoption criteria I mentioned for open models and the bigger question — do I think Gemma 4 will be an overwhelming success? Previous Gemma models have been plagued by tooling issues and poorer performance when being finetuned. Gemma 4’s success is going to be entirely determined by ease of use, to a point where a 5-10% swing on benchmarks wouldn’t matter at all. It’s strong enough, small enough, with the right license, and from the U.S., so many companies are going to slot it in. I’m cautiously optimistic that Gemma 4 is going to work better here. Winds are shifting for open models built in America. We saw GPT-OSS go through a bumpy launch to become an overwhelming success. There’s a collective energy around the likes of Reflection, Arcee, Nemotron, Gemma, Olmo, and peers that show substantial demand for building new stacks around open models. There’s capital to be spent on AI stacks across the economy by those who want more ownership of everything, including the model. After launching The ATOM Project 240 days ago, the conversation is shifting into the next stage. Summer of 2025 was a crisis moment where the U.S. AI scene realized it can’t wait and figure out open models after building AGI. The two markets will capture different areas and proceed in parallel. Now that more companies in the U.S. are releasing strong models, we need to improve the ecosystem so that these models are easy to use, understand, and build value around. It’s the hard work to build another inflection point in these adoption plots I’ve been updating consistently, but that’s the work to be done. Join me in it. More data coming soon! Here’s a sneak peek:
What do you want to know about how space affects human health?
The Artemis II is flying astronauts to orbit the moon. The deep-space flight is a major opportunity to gather data for even longer, riskier missions, especially Mars. What are your questions about how the body copes with radiation, isolation, or weightlessness, and what scientists hope to learn from the mission?
BOJ to raise rates with eye on Iran war fallout, central bank official says
The Bank of Japan will continue to raise interest rates while keeping a close eye on how the Middle East conflict affects the economy and underlying inflation, a senior central bank official said on Friday.
The New Ideas Conundrum in Health Policy
In a new column, President and CEO Dr. Drew Altman writes about the "conundrum of health policy ideas" facing Democrats searching for new proposals because of competing, and complex, priorities: rebuilding Medicaid and the ACA after trillion-dollar cuts, reconstructing federal health agencies, and tackling underlying health care costs, when candidates want simple ideas they can campaign on and voters want their costs to come down.
Proposed Amazon distribution hub draws crowd in Waterville
Camber Development, a Boston-based company, is in the early stages of applying for the permits needed to build a 159,000 square foot building on about 50 acres on Junction Road near Trafton Road.
2026 Perspectives in Private Equity: Sports
Professional sports continue to emerge as an attractive asset class for private equity investors, as evolving ownership dynamics, attractive fundamentals and underlying growth drivers create opportunities. Sports investments offer sponsors an opportunity to diversify portfolios, reduce risk and deliver uncorrelated returns, while tapping into an industry experiencing strong growth driven by continued demand for content, league expansion and the adoption of new revenue models. Sports teams and leagues can also represent unique trophy assets for investors, often delivering intangible value beyond financial returns.
What in the world just happened to the Dow?
Markets are rallying on a familiar bet: That President Donald Trump will, once again, back down. (It’s not called TACO Tuesday for nothing.)
20-hour Amtrak trip from Chicago to New York: What it's really like
Amid the long TSA wait lines, I took a 20-hour Amtrak trip instead of flying. Perks like easier boarding and comfortable seats made the trip better.
The best headphones for flying, according to our frequent-flyer editors
Frequent flyers know great headphones aren’t optional; they’re essential. With more than 200,000 miles flown annually, I rely on them to block noise, reduce fatigue and make every flight more comfortable.
In MA, Doctors’ Day becomes rallying point for health care reform
Facing federal funding cuts and growing primary care shortages, Massachusetts physicians met with legislators on March 25 at the State House.
Military investigating after Kid Rock brags about U.S. Army helicopters flying over his home, will take ‘appropriate action’ if in violation
The military is investigating after Kid Rock bragged about U.S. Army helicopters flying over his Nashville mansion, and say they will take ‘appropriate action’ if in violation.
How The Golden Entertainment (GDEN) Narrative Is Shifting As Analysts Recalibrate Valuation Assumptions
Golden Entertainment’s fair value estimate is set at US$30.50, with no change to the overall target level in the latest update. Analysts are split on what this steady US$30.50 figure means, with bullish voices seeing it as a sign of underlying confidence and bearish voices framing it as a reset that better reflects current risks. Read on to see how this evolving narrative could matter for how you track and interpret Golden Entertainment’s next moves. Stay updated as the Fair Value for Golden...
Is New York's cannabis business really flying high?
Five years after it was legalised, cannabis is seemingly everywhere in New York, but business owners say that many legitimate businesses are struggling.
Startups juice carbon removal with power generation
The era of relying on carbon removal revenue alone is over.
Glyphosate: A story of science, risk, and nuance
In the summer of 2014, a California groundskeeper named Dewayne Johnson started noticing patches of raw, weeping skin spreading across his body. He had spent years applying Roundup, Monsanto’s glyphosate-based herbicide, for a school district, sometimes drenched in it when equipment malfunctioned. By 2014, he had a diagnosis: non-Hodgkin’s lymphoma. In 2018, a jury awarded him $289 million in damages, later reduced on appeal. Tens of thousands of lawsuits followed. The story hasn’t quieted down. It’s all over the internet, swinging between “this will kill you, buy organic” and “relax, you’re fear-mongering.” Some of that recent chatter stems from an Executive Order protecting glyphosate and its production, which set off intense infighting within the MAHA movement. Some of it reflects a deeper truth: Americans genuinely care about harmful chemicals in their environment (see poll below). And the conversation isn’t going anywhere, with a Supreme Court case involving Monsanto set for this April. Glyphosate (the active ingredient in Roundup) is one of the most widely used herbicides in the world. But does glyphosate cause cancer? And how much exposure is actually risky? With so much mistrust in institutions and corporations (and some genuine conflicts of interest), making sense of the actual scientific evidence is genuinely hard. Here is a translation of what the scientific evidence actually says. Does glyphosate cause harm? Glyphosate is an herbicide that kills most plants it contacts rather than targeting specific species. It works by blocking an enzyme pathway (EPSPS) that plants and many microorganisms need to produce essential amino acids. Without those amino acids, the plant can’t grow and dies. Glyphosate was first developed by Monsanto in the 1970s and became ubiquitous after the company introduced “Roundup Ready” crops in the 1990s. In 2024, Bayer removed glyphosate from residential Roundup-branded products due to litigation pressure. But today it is still the most widely used herbicide in the world. Farmers also discovered they could spray it directly on crops like oats, lentils, beans, and peas just before harvest to dry them out faster and make harvesting easier. Because of its widespread use, it’s obviously really important to understand if it’s harmful to humans. The key principle: The dose makes the poison The most important concept in toxicology is that “the dose makes the poison.” Sixteenth-century physician Paracelsus articulated what remains the foundational principle of toxicology: sola dosis facit venenum. Water will kill you if you drink enough of it. Aspirin saves lives at 81 milligrams and causes internal bleeding at higher chronic doses. So, at what dose is glyphosate poisonous? The LD50 in rats (the dose that kills half the test animals) is around 5,600 mg/kg body weight. Table salt is roughly 3,000 mg/kg. By that classic measure, glyphosate is less acutely toxic than salt. But some people are exposed to a lot of glyphosate through their work. And among the general public, there are many questions about low-dose, cumulative exposure from multiple sources over long periods. Does glyphosate cause health problems? Cancer Correlation maps are striking, with one analysis finding that 60% of counties that spray the most glyphosate have non-Hodgkin’s lymphoma rates above the national average. But correlation alone doesn’t establish cause, which is why animal and human studies matter. In animals: Rat studies are typically what most fear is rooted in, but most people don’t know the study details on the dosage given to rats. A pooled analysis of the 13 most rigorous rat studies found evidence that very high doses, around 55,000 times greater than typical food residue exposure, can cause certain cancers. In humans: One of the strongest studies followed 55,000 herbicide users over 20 years and found no overall increased cancer risk. There was one signal: among those with the highest use, rates of acute myeloid leukemia (AML) appeared elevated. A broader meta-analysis of 18 human studies also found no overall cancer risk, though a separate meta-analysis focused specifically on non-Hodgkin lymphoma found that people with high cumulative glyphosate exposure faced a 41% higher relative risk compared to those with low or no exposure. These human studies are observational studies (randomized controlled trials would be unethical), and meta-analyses are only as reliable as the studies they pool. But the story seems consistent: at very high exposure levels, there may be some cancer risk. But that’s about as far as the science currently takes us. Emerging research: gut and reproductive health Gut: Because glyphosate targets a pathway that exists in some gut bacteria, scientists have questioned whether it could affect the microbiome. In mice, a 2023 University of Iowa study found that glyphosate altered gut bacterial composition and raised markers of intestinal inflammation. A 2024 systematic review found similar patterns: disrupted gut bacteria and problems with the mucus layer that protects the intestinal wall in mice. Whether this translates to humans is an open question. The human gut is highly variable and resistant, and we don't yet have strong studies confirming the same effects in people. Reproductive health: Animal studies have found that glyphosate-based herbicides can interfere with reproductive hormones, including disrupting egg cell development in mice and reducing the number of eggs available in sheep’s ovaries. However, the doses used in these experiments were high, so it’s not yet clear whether the same effects would occur in humans. On the human side, a 2021 pilot study led by Mount Sinai researchers tested urine samples from pregnant women across the U.S. and found glyphosate in 95% of them. The study also found a possible connection between higher glyphosate exposure during pregnancy and a subtle physical difference measured in female newborns. That said, some connections weren’t statistically reliable and this was a small study. The researchers themselves said more and larger studies are needed before drawing firm conclusions. What do regulators say about glyphosate safety? In 2015, the International Agency for Research on Cancer (IARC), part of the World Health Organization, classified glyphosate as "probably carcinogenic to humans" (Group 2A). The classification is worth taking seriously. But, there’s an important distinction: IARC classifies hazard, meaning the potential to cause harm under some conditions. It does not assess risk, which accounts for actual exposure levels and the real-world probability of harm. The U.S. EPA, the European Food Safety Authority, Health Canada, and regulatory agencies in Australia and Japan have all concluded that glyphosate is “unlikely to be carcinogenic to humans” at realistic exposure levels. They’re asking a different question: given how much of this people actually encounter, what is the probability of harm? Your actual exposure is what determines your actual risk. What does glyphosate mean for your daily life? At the grocery store: Food residues are small. The EPA’s acceptable daily intake is 1.75 mg/kg of body weight per day. To hit that threshold from oatmeal alone, a 150-pound adult would need to eat roughly 50 pounds of oats every day. But this calculation addresses only one pathway (food), and we don’t yet have robust tools to measure people’s actual total exposure. If reducing exposure matters to you, organic certification prohibits synthetic herbicides, and organic oat products generally test at lower or undetectable levels. Either way, a diet rich in whole grains, conventional or organic, is far better for your health than one that omits them out of fear of residues. On the farm: Occupational exposure is orders of magnitude higher than consumer exposure. Farmers and farm workers who mix, load, and apply glyphosate-based herbicides, especially without protective equipment, face meaningfully different risk profiles. Proper PPE isn’t optional. Integrated weed management strategies that rotate chemical modes of action are also worth taking seriously, both for health and for long-term effectiveness. If you live near a farm: Spray drift is real. Concentrations near field edges can spike during and after application, particularly on windy days. This is an area where I think public health could really step up and empower rural communities with buffer zones, rather than placing the onus on individuals. But for now, knowing your local agricultural calendar and keeping windows closed during application are the first steps. Bottom line Dewayne Johnson was exposed to glyphosate at levels most people will never encounter, and a jury decided he deserved compensation. That outcome is not evidence that the oatmeal in your pantry is dangerous. But it is a reminder that the dose, the context, and the person doing the exposing all matter enormously. Glyphosate is a chemical tool with benefits, trade-offs, and genuine open scientific questions. Learning to hold that complexity without collapsing into panic or dismissal is, honestly, one of the most useful and hardest things to do in navigating modern health science. Love, YLE Your Local Epidemiologist (YLE) is founded and operated by Dr. Katelyn Jetelina, MPH PhD—an epidemiologist, wife, and mom of two little girls. Hannah Totte, MPH, is an epidemiologist and YLE Community Manager. YLE reaches more than 425,000 people in over 132 countries with one goal: “Translate” the ever-evolving public health science so that people will be well-equipped to make evidence-based decisions. This newsletter is free to everyone, thanks to the generous support of fellow YLE community members. To support the effort, subscribe or upgrade below: Subscribe
Russia turned cheap 'Molniya' strike drones into advanced recon tools
The modifications allow Russia to use these drones for battlefield reconnaissance instead of relying on more expensive platforms.
Supreme Court to scrutinize former policy of turning away asylum seekers at southern border
The Supreme Court on Tuesday will consider the legality of a policy championed by President Donald Trump during his first term that prevented scores of migrants arriving at the southern border from starting the process of applying for asylum.
We’ve Been Underestimating Flying Foxes
Australia used to incinerate the large fruit bats, but research suggests they bring hundreds of millions of dollars in benefits to the country’s economy.